Lucid Diagnostics (LUCD) Interest Coverage Ratio Growth (1y) (2021 - 2026)
Lucid Diagnostics (LUCD) Interest Coverage Ratio Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -71.56% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 68.09% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 28.95% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 34.84% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 12.01% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -29.36% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 16.91% |
| 10 | Lucid Diagnostics | 176.64 Mn | 143.24 Mn | 55,000.00 | -68.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -85.49% |
| Mar 31, 2026 | -12.90% |
| Dec 31, 2025 | -4,787.34% |
| Sep 30, 2025 | 66.14% |
| Jun 30, 2025 | 83.29% |
| Mar 31, 2025 | 36.74% |
| Dec 31, 2024 | -309.84% |
| Sep 30, 2024 | -0.45% |
| Jun 30, 2024 | -52.54% |
| Mar 31, 2024 | 80.25% |
| Dec 31, 2023 | 3.55% |
| Sep 30, 2023 | -385.82% |
| Jun 30, 2023 | 60.96% |
| Mar 31, 2023 | 8.30% |
| Dec 31, 2022 | 112.72% |
| Sep 30, 2022 | 54.68% |
| Jun 30, 2022 | -13.11% |
| Dec 31, 2021 | -30,313.21% |